| KRJ-I and BON cell lines: defining an appropriate enterochromaffin cell neuroendocrine tumor model. | |
| | |
MedLine Citation:
|
PMID: 19295186 Owner: NLM Status: In-Process |
Abstract/OtherAbstract:
|
BACKGROUND: Neuroendocrine tumors (NETs) of the gastrointestinal (GI) system are increasing in incidence with minimal improvement in prognosis. Although the cell of origin has been identified as the enterochromaffin (EC) cell, its secretory and proliferative regulation has not been defined at a mechanistic level. To date, the BON cell line has been the most widely used in vitro EC cell model despite its pancreatic origin. Using whole-genome mathematical analysis as well as secretory and proliferative studies, we compared the BON cell line to the small intestine (SI) EC cell-derived NET cell line, KRJ-I, to assess individual cell line validity and applicability for the investigation of GI-NET disease. METHODS AND RESULTS: Principal component analysis and ANOVA of KRJ-I and BON transcriptomes (U133 Plus 2) identified substantially different (<10%) overlap in transcripts with minimal (R(2) = 0.24) correlation in gene expression profiles. RT-PCR detected large variability (>12%) in neuroendocrine (NE) marker transcripts in the BON cell line and the absence of Tph-2, DDC, TGFbetaR2, and M3 transcripts in KRJ-I. The KRJ-I cell line secreted serotonin (5-HT) in response to isoproterenol (EC(50) = 100 nM), noradrenaline (EC(50) = 1.7 nM), and pituitary adenylate cyclase (PACAP, EC(50) = 0.03 nM). Cholecystokinin (IC(50) = 430 nM), somatostatin (IC(50) = 400 nM), acetylcholine (IC(50) = 3.7 nM), and gamma-aminobutyric acid A (GABA(A), IC(50) = 2 nM) all inhibited 5-HT release, while gastrin and bombesin had no effect. 5-HT secretion in the BON cell line was stimulated by isoproterenol (EC(50) = 900 nM), noradrenaline (EC(50) = 20 nM), cholecystokinin (EC(50) = 130 nM), PACAP (EC(50) = 0.12 nM), bombesin (EC(50) = 15 nM), and acetylcholine (EC(50) = 0.2 nM). It was inhibited by somatostatin (IC(50) = 300 nM) but not GABA(A). KRJ-I responded with proliferation to connective tissue growth factor (CTGF, EC(50) = 0.002 ng/ml), transforming growth factor-alpha (TGFalpha, EC(50) = 0.63 ng/ml) and transforming growth factor-beta (TGFbeta, EC(50) = 0.63 ng/ml). Epidermal growth factor (EGF) and somatostatin had no significant effect. BON cell proliferation was stimulated only by EGF and TGFalpha (EC(50) = 15.8 and 10 ng/ml). TGFbeta (IC(50) = 0.16 ng/ml), MZ-4-147 (IC(50) = 0.5 nM), and BIM23A761 (IC(50) = 0.06 nM) all inhibited proliferation. CTGF and somatostatin had no effect. CONCLUSION: KRJ-I and BON cell lines demonstrate substantial differences in gene level transcripts, inconsistent receptor profile expression, wide variability in NE marker transcript levels, and significantly differential proliferative and secretory responses. Given the EC cell origin of KRJ-I, these results provide evidence that the BON cell line does not represent an EC cell system and is not a valid study model of (carcinoid) EC cell-derived NET. |
| | |
Authors:
|
Zakiya-Luna Siddique; Ignat Drozdov; Jared Floch; Bjorn I Gustafsson; Kamilla Stunes; Roswitha Pfragner; Mark Kidd; Irvin M Modlin |
Related Documents
:
|
8369016 - Effects of macrophage colony-stimulating factor on the proliferation and the function o... 11306136 - Inhibition of egg hatching success and larvae survival of the scallop, chlamys farreri,... 16665626 - Photosynthetic characteristics of a photoautotrophic cell suspension culture of soybean. 15296446 - Quantitative studies of cell-bubble interactions and cell damage at different pluronic ... 22388916 - Engineering of contact resistance between transparent single-walled carbon nanotube fil... 17048046 - The role of trypsin, trypsin inhibitor, and trypsin receptor in the onset and aggravati... |
Publication Detail:
|
Type: Comparative Study; Journal Article Date: 2009-03-18 |
Journal Detail:
|
Title: Neuroendocrinology Volume: 89 ISSN: 1423-0194 ISO Abbreviation: Neuroendocrinology Publication Date: 2009 |
Date Detail:
|
Created Date: 2009-06-04 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0035665 Medline TA: Neuroendocrinology Country: Switzerland |
Other Details:
|
Languages: eng Pagination: 458-70 Citation Subset: IM |
Copyright Information:
|
Copyright 2009 S. Karger AG, Basel. |
Affiliation:
|
Gastrointestinal Pathobiology Research Group, Yale University School of Medicine New Haven, New Haven, CT 06520-8062, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The psoriasis family index: preliminary results of validation of a quality of life instrument for fa...
Next Document: Diffuse bleeding from the bronchial mucosa on flexible bronchoscopy in lung transplanted patients: '...